Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liposomal bupivacaine fascia iliaca block for postoperative pain in elderly THA
ChiCTR2600116149Phase 4Not yet recruiting
- Sponsor
- Huainan First People's Hospital
- Start
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of bupivacaine in postoperative pain and post-total hip arthroplasty pain (3 arms), sponsored by Huainan First People's Hospital. Primary endpoint: Postoperative resting and movement NRS pain intensity AUC. Planned start Jan 2026; status: not yet recruiting.
02
Drugs
bupivacaine
03
Conditions
postoperative painpost-total hip arthroplasty pain
Beyond the preview
Go deeper on ChiCTR2600116149.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600116149.